Also trades as: NRSN (NASDAQ) · $vol 0M
NRSNW NASDAQ
NeuroSense Therapeutics Ltd.
1W: -51.9%
1M: +10.2%
3M: -51.9%
YTD: -66.8%
1Y: -60.0%
3Y: -58.3%
$0.10
+0.04 (+66.67%)
Weekly Expected Move ±187.2%
$-0
$-0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.5M
52W Range0.0697-0.3
Volume3,868
Avg Volume1,122
Beta1.56
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAlon Ben-Noon
Employees16
SectorHealthcare
IndustryBiotechnology
IPO Date2021-12-09
Websiteneurosense-tx.com
Medinat ha-Yehudim Street 85
Herzliya, TA 4676670
IL
Herzliya, TA 4676670
IL
972 9 953 1142
About NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd. is an Israeli clinical-stage biotechnology firm dedicated to pioneering novel therapies for severe neurodegenerative conditions. Its most advanced investigational asset is PrimeC, an innovative oral compound specifically engineered to address amyotrophic lateral sclerosis (ALS). Beyond its lead program, the company boasts a preclinical pipeline featuring StabiliC, aimed at Parkinson's disease, and CogniC, targeting Alzheimer's disease. Established in Herzliya, Israel, in 2017, NeuroSense Therapeutics continues to advance its therapeutic initiatives.
Latest News
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Given Consensus Recommendation of “Moderate Buy” by Analysts
NeuroSense Announces Pricing of Insider-Led PIPE Financing
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Short Interest Up 21.3% in March
Brokerages Set NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Price Target at $8.50
NeuroSense Therapeutics receives Nasdaq notices over listing requirements
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Eisenberg Or | A-Award | 200,000 | — | 2026-03-26 |
| Russek-Blum Niva | A-Award | 200,000 | — | 2026-03-26 |
| Binder Hagit | A-Award | 200,000 | — | 2026-03-26 |
| Eisenberg Or | 0 | — | 2026-03-18 | |
| Eisenberg Or | 0 | — | 2026-03-18 |